MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Long-term follow-up of subthalamic nucleus deep brain stimulation for Parkinson’s disease: survival and disability milestones

    R. Barbosa, L. Correia-Guedes, M. Cattoni, P. Pita-Lobo, A. Castro-Caldas, M. Fabbri, P. Bastos, H. Carvalho, L. Albuquerque, S. Reimão, A. Gonçalves Ferreira, J. Ferreirajos, M. Rosa, M. Coelho (Lisbon, Portugal)

    Objective: To characterize retrospectively the long-term survival of 109 PD patients after 8 years of STN-DBS and to identify the incidence of the milestones of…
  • 2022 International Congress

    Cortical beta activity in doorway-provoked motor blocks in Parkinson’s disease

    S. Tran, J. Baarbe, R. Chen (Toronto, Canada)

    Objective: To investigate cortical activity of doorway-provoked motor blocks (MB) during pedalling in Parkinson’s disease (PD). Background: Freezing of gait (FOG) is common in PD…
  • 2022 International Congress

    Motor-Related and Cognition-Related Safety of Pimavanserin in Patients with Parkinson’s Disease Psychosis (PDP)

    V. Abler, C. Ballard, A. Berrio, B. Coate, C. Brain, A. Espay (San Diego, USA)

    Objective: Evaluate motor- and cognition-related safety in pimavanserin-treated patients with PDP. Background: Pimavanserin, a selective 5-HT2A inverse agonist/antagonist, is the only US FDA-approved treatment for…
  • 2022 International Congress

    Chronotype and Cognition in Veterans with Parkinson’s Disease

    A. Sarwar (Houston, USA)

    Objective: To determine if chronotype impacts the expression of dementia and/or depression in Veterans with Parkinson's disease (PD). Background: Chronotype reflects the periodicity of biological…
  • 2022 International Congress

    Use of virtual reality devices for the monitoring of Parkinson’s disease

    S. Hirczy, M. Salinas (Dallas, USA)

    Objective: To determine whether mass market virtual reality (VR) devices can be used to detect the motor manifestations of Parkinson’s disease and their response to…
  • 2022 International Congress

    Preliminary Verification of a Kinect-based System for Evaluating Postural Abnormalities in Patients with Parkinson’s Disease

    RH. Hong, Z. Wu, TY. Zhang, ZY. Zhang, XY. Su, Y. Jin, YC. Gao, LZ. Pan, HP. Zhi, Q. Guan, LJ. Jin (Shanghai, China)

    Objective: In this study, we initially tested the reliability and validity of a Kinect-based system developed by our team with a cohort of small sample…
  • 2022 International Congress

    The frequency of glucocerebrosidase mutations in a subgroup of early-onset Parkinson’s disease patients in the Korean population

    J. Lee, J. Hwangbo (Yangsan, Republic of Korea)

    Objective: We investigated the frequency of GBA mutations in the Korean patients with early-onset Parkinson’s disease (PD). Background: Glucocerebrosidase (GBA) mutations are associated with increased…
  • 2022 International Congress

    Motor resonance flexibility to emotion-enriched context in Parkinson’s disease patients with and without freezing of gait.

    E. Pelosin, G. Lagravinese, A. Bisio, M. Bove, A. Botta, G. Bonassi, R. Marchese, S. Mezzarobba, P. Ruggeri, L. Avanzino (Genova, Italy)

    Objective: This study aims at exploring the response of the mirror neuron system, specifically motor resonance, to an emotion-enriched context in people with Parkinson disease…
  • 2022 International Congress

    Characterization of gastrointestinal dysfunction in Parkinson’s by disease stage

    M. Camacho, J. Greenland, D. Apostolopoulos, C. Daruwalla, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To conduct a comprehensive cross-sectional and longitudinal characterization of gastrointestinal dysfunction (GID) in Parkinson’s disease (PD). Background: GID is an important feature of PD…
  • 2022 International Congress

    Can we add whey protein supplementation in patients with Parkinson’s disease without interfering with levodopa response?

    G. Pinelli, C. Siri, A. Ranghetti, V. Cereda, R. Maestri, M. Canesi (Gravedona, Italy)

    Objective: The main endpoint of the study was to evaluate if a daily intake of whey protein-based dietary supplement causes a worse response to levodopa…
  • « Previous Page
  • 1
  • …
  • 311
  • 312
  • 313
  • 314
  • 315
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley